GL1X · GenesisL1 explorer

UniProt Q6DHI5

Q6DHI5

Q6DHI5 (UniProt Q6DHI5): 25 experimental structures on GenesisL1, 7 ligands bound. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q6DHI5
Experimental structures
25
Predicted models
0
Ligands
7

Structures

25 records of Q6DHI5 in the MolNFT archive: 25 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
4UTNCrystal structure of zebrafish Sirtuin 5 in complex with succinylated CPS1-peptidex-ray diffractionA, B——
4UTNCrystal structure of zebrafish sirtuin 5 in complex with succinylated CPS1-peptidex-ray diffractionA, B——
4UTRCrystal structure of zebrafish Sirtuin 5 in complex with glutarylated CPS1-peptidex-ray diffractionA, B——
4UTRCrystal structure of zebrafish sirtuin 5 in complex with glutarylated CPS1-peptidex-ray diffractionA, B——
4UTVCrystal structure of zebrafish Sirtuin 5 in complex with 3-phenyl- succinylated CPS1-peptidex-ray diffractionA, B——
4UTVCrystal structure of zebrafish sirtuin 5 in complex with 3-phenyl- succinylated CPS1-peptidex-ray diffractionA, B——
4UTXCrystal structure of zebrafish Sirtuin 5 in complex with 3-nitro- propionylated CPS1-peptidex-ray diffractionA, B——
4UTXCrystal structure of zebrafish sirtuin 5 in complex with 3- nitro-propionylated CPS1-peptidex-ray diffractionA, B——
4UTZCrystal structure of zebrafish Sirtuin 5 in complex with adipoylated CPS1-peptidex-ray diffractionA, B——
4UTZCrystal structure of zebrafish sirtuin 5 in complex with adipoylated CPS1-peptidex-ray diffractionA, B——
4UU7Crystal structure of zebrafish Sirtuin 5 in complex with 3-methyl- succinylated CPS1-peptidex-ray diffractionA, B——
4UU7Crystal structure of zebrafish sirtuin 5 in complex with 3- methyl-succinylated CPS1-peptidex-ray diffractionA, B——
4UU8Crystal structure of zebrafish Sirtuin 5 in complex with 3,3-dimethyl- succinylated CPS1-peptidex-ray diffractionA, B——
4UU8Crystal structure of zebrafish sirtuin 5 in complex with 3, 3-dimethyl-succinylated CPS1-peptidex-ray diffractionA, B——
4UUACrystal structure of zebrafish Sirtuin 5 in complex with 3S-Z-amino- succinylated CPS1-peptidex-ray diffractionA, B——
4UUACrystal structure of zebrafish sirtuin 5 in complex with 3S- Z-amino-succinylated CPS1-peptidex-ray diffractionA, B——
4UUBCrystal structure of zebrafish Sirtuin 5 in complex with 2R-butyl- succinylated CPS1-peptidex-ray diffractionA, B——
4UUBCrystal structure of zebrafish sirtuin 5 in complex with 2R- butyl-succinylated CPS1-peptidex-ray diffractionA, B——
5OJOSirtuin 5 from danio rerio in complex with 3-hydroxy-3-methylglutaryl- CPS1 peptidex-ray diffractionA, BZN, NA—
6ENXZebrafish SIRT5 in complex with stalled bicyclic intermediate of inhibitory compound 10x-ray diffractionAZN, BJW—
6EO0Zebrafish SIRT5 in complex with stalled peptidylimidate and bicyclic intermediate of inhibitory…x-ray diffractionA, B, C, DZN, BV8, BVT—
6FKYCrystal structure of zebrafish sirtuin 5 in complex with 3- (BENZYLTHIO)SUCCINYL-CPS1 peptidex-ray diffractionA, BZN, NA, E9N, DZK—
6FKZCrystal structure of zebrafish sirtuin 5 in complex with 3- (PHENYLTHIO)SUCCINYL-CPS1 peptidex-ray diffractionA, BZN—
6FLGCrystal structure of zebrafish sirtuin 5 in complex with 3(S)- (NAPHTHYLTHIO)SUCCINYL-CPS1 peptidex-ray diffractionA, BZN—
Q6DHI5AlphaFold monomer V2.0 prediction for NAD-dependent protein deacylase sirtuin-5, mitochondrial…———

Ligands

  • ZN · Zinc ion · in 6 records
  • NA · Sodium ion · in 2 records
  • BJW · 4-[(2~{R},3~{A}~{R},5~{R},6~{R},6~{A}~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-2-[[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino) hexyl]amino]-6-oxidanyl-3~{A},5,6,6~{A}-tetrahydrofuro[2,3-d][1,3]oxathiol-2-yl]butanoic acid · in 1 record
  • BV8 · 3-[[(~{Z})-~{C}-[(2~{R},3~{R},4~{S},5~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]sulfanyl-~{N}-[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino) hexyl]carbonimidoyl]amino]propanoic acid · in 1 record
  • BVT · 3-[[(2~{S},3~{A}~{R},5~{R},6~{R},6~{A}~{R})-5-[[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3, 4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-2-[[(5~{S})-6-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanylidene-1-(propan-2-ylamino)propan-2-yl]amino]-6-oxidanylidene-5-(phenylmethoxycarbonylamino) hexyl]amino]-6-oxidanyl-3~{A},5,6,6~{A}-tetrahydrofuro[2,3-d][1,3]oxathiol-2-yl]amino]propanoic acid · in 1 record
  • DZK · (2~{S})-2-(phenylmethylsulfanyl)butanedioic acid · in 1 record
  • E9N · (2~{R})-2-(phenylmethylsulfanyl)butanedioic acid · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.